Journal of the International Aids Society
-
Publication Venue For
-
The passing of an AIDS Activist: in memorium, Archbishop Desmond Mpilo Tutu.
25.
2022
-
Broadly neutralizing monoclonal antibodies for HIV prevention..
24 Suppl 7:e25829.
2021
-
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies..
24 Suppl 7:e25831.
2021
-
Preferences for transitional HIV care among people living with HIV recently released from prison in Zambia: a discrete choice experiment..
24:e25805.
2021
-
Comparing recruitment strategies to engage hard-to-reach men who have sex with men living with HIV with unsuppressed viral loads in four US cities: Results from HPTN 078..
24:e25798.
2021
-
Overview of the epidemiological conditions of HIV among key populations in Africa..
24 Suppl 3:e25716.
2021
-
Mental health interventions for persons living with HIV in low- and middle-income countries: a systematic review..
24 Suppl 2:e25722.
2021
-
An evaluation of assumptions underlying respondent-driven sampling and the social contexts of sexual and gender minority youth participating in HIV clinical trials in the United States..
24:e25694.
2021
-
Ending unjust HIV criminalization: leave no-one behind..
24:e25681.
2021
-
Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective..
23 Suppl 1:e25499.
2020
-
Challenges and facilitators of transition from adolescent to adult HIV care among young adults living with HIV in Moshi, Tanzania..
22:e25406.
2019
-
Getting youth PrEPared: adolescent consent laws and implications for the availability of PrEP among youth in countries outside of the United States..
22:e25363.
2019
-
Section 377: Why sodomy statutes matter..
22:e25285.
2019
-
Improvements in the HIV care continuum needed to meaningfully reduce HIV incidence among men who have sex with men in Baltimore, US: a modelling study for HPTN 078..
22:e25246.
2019
-
Using theory of change frameworks to develop evaluation strategies for research engagement: results of a pre-pilot study..
21 Suppl 7:e25181.
2018
-
Expert consensus statement on the science of HIV in the context of criminal law..
21:e25161.
2018
-
HIV viral load monitoring among key populations in low- and middle-income countries: challenges and opportunities..
20 Suppl 7.
2017
-
Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure..
20:21930.
2017
-
The science of Durban, AIDS 2016..
20:21781.
2017
-
New HIV testing technologies in the context of a concentrated epidemic and evolving HIV prevention: qualitative research on HIV self-testing among men who have sex with men and transgender women in Yangon, Myanmar..
20:21796.
2017
-
Latent class analysis of acceptability and willingness to pay for self-HIV testing in a United States urban neighbourhood with high rates of HIV infection..
20:21290.
2017
-
Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy..
19:21108.
2016
-
Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis..
19:21106.
2016
-
HIV-1 subtype C is significantly more infectious than other subtypes.
18.
2015
-
Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1.
18.
2015
-
The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries..
18:20282.
2015
-
First prospective comparison of genotypic vs phenotypic tropism assays in predicting virologic responses to Maraviroc (MVC) in a phase 3 study: MODERN.
17:19519-19519.
2014
-
A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa..
17:19152.
2014
-
Comparing patterns of sexual risk among adolescent and young women in a mixed-method study in Tanzania: implications for adolescent participation in HIV prevention trials..
17:19149.
2014
-
In memoriam: Joep Lange MD, PhD..
17:19401.
2014
-
Maximizing the benefits of antiretroviral therapy for key affected populations..
17:19320.
2014
-
The global battle for sexual rights..
17:19243.
2014
-
Widow cleansing and inheritance among the Luo in Kenya: the need for additional women-centred HIV prevention options..
17:19010.
2014
-
HIV now: why human rights matter more than ever..
16:18968.
2013
-
A pilot cohort study to assess the feasibility of HIV prevention science research among men who have sex with men in Dakar, Senegal..
16 Suppl 3:18753.
2013
-
HIV among men who have sex with men in Malawi: elucidating HIV prevalence and correlates of infection to inform HIV prevention..
16 Suppl 3:18742.
2013
-
The HIV epidemic and human rights violations in Brazil..
16:18817.
2013
-
Home-based mental health services are associated with improved mental health outcomes among individuals with HIV.
15:173-173.
2012
-
Methamphetamine use is associated with sexual abuse and HIV sexual risk behaviours among patrons of alcohol serving venues in Cape Town, South Africa.
15:89-90.
2012
-
A cross-sectional assessment of population demographics, HIV risks and human rights contexts among men who have sex with men in Lesotho..
14:36.
2011
-
Visioning services for children affected by HIV and AIDS through a family lens..
13 Suppl 2:I1.
2010
-
India-US collaboration to prevent adolescent HIV infection: the feasibility of a family-based HIV-prevention intervention for rural Indian youth..
12:35.
2009
-
The role of disclosure in relation to assent to participate in HIV-related research among HIV-infected youth: a formative study..
12:17.
2009
-
Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone
2022
-
Cumulative HIV-1 viremia is associated with multimorbidity among US women with HIV
2022
-
First-in-human evaluation of safety and pharmacokinetics of intravenous or subcutaneous infusions of PGT121.141.LS, an anti-V3 HIV-1 broadly neutralizing antibody in healthy volunteers without HIV
2022
-
Immune correlates analysis of the Imbokodo HIV-1 vaccine efficacy trial
2022
-
Amplifying youth voices in HIV prevention: lessons learned from a community-based adolescent health project in Durham, NC
2021
-
Combination therapy with the broadly neutralizing antibody VRC07-523LS and the latency reversal agent Vorinostat fails to substantially reduce latent, resting CD4+T cell infection or reduce low-level viremia
2021
-
Comparison of co-immunization of DNA and protein in the same anatomical sites and in contralateral sites to identify mechanisms of protective immune response
2021
-
Improved killing of HIV-infected cells by a combination of three neutralizing and non-neutralizing antibodies
2021
-
Similar antibody responses to subtype C ALVAC-HIV/gp120 vaccine regimens using different adjuvants (MF59 vs. alum) but enhanced response rates and magnitude when ALVAC-HIV and gp120 were co-administered
2021
-
Co-immunization of DNA and protein in the same anatomical sites induces superior protective immune responses against SHIV challenge
2020
-
Sequence and structure guided HIV-1 clade C trimeric immunogen design to induce neutralizing and V1V2 directed antibody responses
2020
-
ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26. Mos4. HIV and either clade C gp140 or bivalent gp140
2019
-
Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521 Delta 11mutC) and CD4-induced gp120 (rhFLSC) proteins
2019
-
Social-media based secondary distribution of HIV self-testing among Chinese men who have sex with men: A pilot implementation programme assessment
2019
-
"My best friends and my worst enemies:" understanding the roles of families in retaining South African adolescents living with HIV in care
2018
-
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge
2018
-
Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein
2018
-
Oral MVA/protein HIV vaccination with a needle-free injector induces robust systemic and mucosal antibody responses in rhesus macaques
2018
-
Time to treatment initiation for drug-resistant tuberculosis is delayed in a South African prospective cohort
2017
-
SOF/VEL single-tablet regimen in HCV mono-infected and HIV/HCV co-infected patients: comparison of efficacy and safety data from phase 3 clinical trials
2016
-
Deferred antiretroviral therapy is associated with lower estimated glomerular filtration rate in HIV-positive individuals with high CD4 counts
2016
-
Elimination of HIV-1 latently infected cells by PKC agonist gnidimacrin alone and in combination with a histone deacetylase inhibitor
2016
-
Meeting the "Go'' criteria: immunogenicity from HVTN100, a phase 1/2 randomized, double blind, placebo-controlled trial of clade C ALVAC-(R) (vCP2438) and Bivalent Subtype C gp120/MF59 (R) in HIV-uninfected South African adults
2016
-
Optimizing the frequency of kidney safety monitoring in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis
2016
-
Sofosbuvir/velpatasvir fixed dose combination for 12 weeks in patients co-infected with HCV and HIV-1: the phase
2016
-
Streamlined quasispecies and subtype analysis of HIV-1 sequences generated by high-throughput sequencing using the high-performance integrated virtual environment (HIVE)
2016
-
Treatment interruptions in HIV cure studies in the United States: perceptions, motivations and ethical considerations from potential HIV-positive volunteers
2016
-
HIV-1-specific IgG antibody levels correlate with the presence of a specific HLA class II allele to impact acquisition and vaccine efficacy
2015
-
Network-level factors associated with IPV perpetration among young urban Tanzanian men
2015
-
Integration of global techniques to implicate post-transcriptional regulation in HIV infection
2012